Aug16Thu, 08/16/2018 - 15:00 to 16:00Join BRANY (Biomedical Research Alliance of New York), the creator of Protocol Builder for a free introductory webinar/live demo of this novel protocol development tool. Designed to help you and your colleagues get more out of Protocol Builder faster, this session will focus on general Protocol Builder use for investigators, research administration and residency programs.
Aug30Thu, 08/30/2018 - 15:00 to 16:00Join BRANY (Biomedical Research Alliance of New York), the creator of Protocol Builder for a free advanced-level webinar/live demo of this novel protocol development tool. Primarily developed for Residents and New Investigators (but open to all users), this session will focus on advanced features including References Library import from external sources, advanced collaboration features, and summary of changes.
Sep13Thu, 09/13/2018 - 15:00 to 16:00Join VICTR (Vanderbilt University CTSA), the creator of ResearchMatch for a free webinar/live demo of this novel research registry. Learn how to register your studies, create a cohort of potential volunteers, and send out contact messages and surveys. They will also cover how to send a pre-screening (eligibility) survey, contact the volunteers that replied 'yes' to your initial message, and manage your enrollment continuum.
June 7th, 2018
Translating Translation "NCATS is unique at NIH in that the name in the Center’s mission — “translation” — has a firmly
established meaning that is generally associated with languages, not biomedical research. By contrast, other NIH
components are named for widely known medical problems, such as cancer, diabetes and stroke."
June 4th, 2018
"The modern news release is now directly consumed by the public. Here are some of the best practices gathered by NIH
communications offices for writing clear news releases that also inform the public about a scientific finding."
June 4th, 2018
In late April, Dr. Mike Lauer, NIH Deputy Director for Extramural Reserach, wrote about the benefits and drawbacks
of using surrogate endpoints in clinical trials. Read his thoughts here...